NB BIOTINA M 500

NB BIOTINA M 500 is a specially designed once-daily tablet aimed at individuals diagnosed with Type 2 Diabetes who have not achieved sufficient glucose control with Metformin alone or who are looking for a complementary therapeutic approach to optimize their blood sugar management. This formulation integrates two effective mechanisms of action, providing comprehensive 24-hour blood glucose regulation, which may help lower the likelihood of serious long-term complications associated with diabetes, such as renal impairment, neuropathy, vision loss, cardiovascular events, and strokes. The approach utilized in NB BIOTINA M 500 consists of Metformin and Teneligliptin, each contributing uniquely to glucose control. Metformin, a biguanide at a dosage of 500mg, is primarily responsible for diminishing hepatic glucose synthesis and enhancing insulin sensitivity in muscle and adipose tissues, facilitating glucose uptake from the bloodstream while reducing absorption in the intestines. It is widely recognized as a first-line treatment due to its effectiveness, safety profile, and potential for modest weight reduction. Teneligliptin, a DPP-4 inhibitor at 20mg, works by prolonging the action of incretin hormones, thus promoting insulin secretion from the pancreas in a manner dependent on glucose levels while also curbing glucagon release that can raise blood sugar. This combination addresses multiple facets of Type 2 Diabetes pathology, leading to better glucose control than either medication alone. The drug not only shows promise in lowering HbA1c, indicating improved long-term glucose management, but also minimizes the risk of hypoglycemia, particularly when not used in combination with insulin or sulfonylureas. With its continuous action throughout the day, it supports consistent regulation of blood sugar levels during fasting and after meals. Furthermore, the combined formulation reduces the number of pills necessary, enhancing medication adherence, which is crucial for effective diabetes management.